Related Experiment Video
Updated: May 9, 2026
Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis
Fabienne L Gray1, Christopher G Turner, David Zurakowski
1Department of Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA.
Insights
High Pediatric Ulcerative Colitis Activity Index (PUCAI) scores strongly predict the need for staged surgery. Preoperative tacrolimus therapy significantly improves PUCAI in pediatric ulcerative colitis patients.
Area of Science:
- Pediatric Gastroenterology
- Surgical Gastroenterology
- Clinical Outcomes Research
Background:
- Pediatric ulcerative colitis (UC) management often involves complex surgical decisions.
- The Pediatric Ulcerative Colitis Activity Index (PUCAI) is a key tool for assessing disease severity.
- Tacrolimus is an immunosuppressive agent used in refractory UC.
Purpose of the Study:
- To examine the correlation between the PUCAI and the type of operative management in pediatric UC patients.
- To evaluate the efficacy of tacrolimus in improving PUCAI prior to surgery.
Main Methods:
- Retrospective review of pediatric UC patients (≤21 years) undergoing restorative proctocolectomy with ileal pouch-anal anastomosis.
- Analysis of pre-operative PUCAI, procedure type (combined vs. staged), and postoperative complications.
- Assessment of PUCAI changes and side effects in patients receiving tacrolimus preoperatively.
Main Results:
- A higher pre-operative PUCAI was significantly associated with undergoing a staged procedure (p < 0.001).
- Forty-four patients (73%) received tacrolimus, showing significant PUCAI improvement (p < 0.001).
- Tacrolimus had minor, reversible side effects, and complication rates were not significantly altered.
Conclusions:
- The PUCAI is a strong predictor of the need for staged surgical procedures in pediatric UC.
- Preoperative tacrolimus therapy demonstrates significant efficacy in reducing disease activity (PUCAI) before surgery.
Purpose:
The primary purpose of this study was to investigate the relationship between Pediatric Ulcerative Colitis Activity Index (PUCAI) and operative management. We also specifically evaluated those patients receiving tacrolimus for their disease.
Methods:
A retrospective review (1/06-1/11) identified ulcerative colitis patients (≤21 years old) undergoing restorative proctocolectomy with rectal mucosectomy and ileal pouch-anal anastomosis. Main outcomes included pre-operative PUCAI, combined versus staged procedure, and postoperative complications. Patients receiving tacrolimus within 3 months of surgical intervention were identified. PUCAI at tacrolimus induction and medication side effects were also noted.
Results:
Sixty patients were identified. Forty-two (70%) underwent combined and 18 (30%) had staged procedures. Pre-operative PUCAI was lower for combined versus staged patients (p = < 0.001). Furthermore, a higher pre-operative PUCAI strongly correlated with the likelihood of undergoing a staged procedure (p < 0.001). Forty-four patients (73%) received tacrolimus. Significant improvement in their PUCAI was noted from induction to pre-operative evaluation (p < 0.001). Minor and reversible side effects occurred in 46% of patients receiving tacrolimus, but complication rates were not significantly different.
Conclusions:
There is a very strong correlation between the PUCAI and the likelihood of undergoing a staged procedure. A significant improvement in PUCAI occurs following preoperative tacrolimus therapy.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:29Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...